Incretin-based glucose-lowering medications and the risk of acute pancreatitis and malignancies: a meta-analysis based on cardiovascular outcomes trials

Citation
El Aziz MA, Cahyadi O, Meier JJ, et al. Diabetes Obes Metab 2020;22:699–704.